Antiplatelet therapy and risk of stroke
- 30 September 1993
- journal article
- Published by Elsevier in Annals of Epidemiology
- Vol. 3 (5) , 568-570
- https://doi.org/10.1016/1047-2797(93)90118-n
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Are both aspirin and heparin justified as adjuncts to thrombolytic therapy for acute myocardial infarction?Published by Elsevier ,1993
- Low-dose aspirin and stroke. "It ain't necessarily so".Stroke, 1992
- Aspirin and other antiplatelet agents in the secondary and primary prevention of cardiovascular disease.Circulation, 1989
- Final Report on the Aspirin Component of the Ongoing Physicians' Health StudyNew England Journal of Medicine, 1989
- Secondary prevention of vascular disease by prolonged antiplatelet treatmentBMJ, 1988
- United Kingdom transient ischaemic attack (UK-TIA) aspirin trial: interim resultsBMJ, 1988
- Randomised trial of prophylactic daily aspirin in British male doctorsBMJ, 1988
- Arachidonic Acid Metabolites and the Interactions between Platelets and Blood-Vessel WallsNew England Journal of Medicine, 1979
- A case-control study of regular aspirin use and coronary deaths.Circulation, 1978
- Aspirin and coronary heart disease: findings of a prospective study.BMJ, 1975